Insmed Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business and Pipeline Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Insmed Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business and Pipeline Update

Insmed (INSM) Misses Q4 EPS by 5c

February 17, 2022 7:08 AM EST

Insmed (NASDAQ: INSM) reported Q4 EPS of ($0.95), $0.05 worse than the analyst estimate of ($0.90). Revenue for the quarter came in at $56.1 million versus the consensus estimate of $50.78 million.

For earnings history and earnings-related data on Insmed (INSM) click here.

... More